ResearcherUniversidade do PortoActive in the last 2 years

Rita Rebelo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6439-5959; OpenAlex author ID A5029657252. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems. Co-author DOI 10.1016/j.semcancer.2024.09.002 ↗
Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Co-author DOI 10.1016/j.molmed.2023.03.002 ↗
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ph14030280 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cristina P. R. Xavier · 3 shared papers, 2021–2024 · strength 0.63
Elisa Giovannetti · 2 shared papers, 2023–2024 · strength 0.45
- Paper Fibroblasts in pancreatic cancer: molecular and clinical perspectives. DOI 10.1016/j.molmed.2023.03.002 ↗
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
M. Helena Vasconcelos · 2 shared papers, 2021–2023 · strength 0.44
- Paper Fibroblasts in pancreatic cancer: molecular and clinical perspectives. DOI 10.1016/j.molmed.2023.03.002 ↗
- Paper Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ph14030280 ↗
Benoît Immordino · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Macarena Perán · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Manoj Amrutkar · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Naomi Walsh · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Alessandro Gregori · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Belén Toledo · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Giulia Lencioni · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗
Justo Pastor Castano · 1 shared paper, 2024 · strength 0.19
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.